A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay
NCT ID: NCT01852617
Last Updated: 2015-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6858 participants
INTERVENTIONAL
2011-10-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Implementation of intervention
Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide
Training in smoking cessation counseling
Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide
No implementation of the intervention
Standard in-service activities
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training in smoking cessation counseling
Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* An estimated frequency of women receiving the "5 A's" intervention below 20%
* Having midwives or nurse-midwives as part of the hospital or primary health center staff.
* Having signed a letter of intention to participate in the project.
* Having at least 400 new pregnant women per year.
Exclusion Criteria
12 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tulane University
OTHER
Centers for Disease Control and Prevention
FED
Institute for Clinical Effectiveness and Health Policy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ezequiel Garcia Elorrio
Chief of Administration
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando Althabe, MD
Role: PRINCIPAL_INVESTIGATOR
Institute for Clinical Effectiveness and Health Policy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Lucio Meléndez
Adrogué, Buenos Aires, Argentina
Hospital Evita Pueblo
Berazategui, Buenos Aires, Argentina
Hospital M.V de Martínez
General Pacheco, Buenos Aires, Argentina
Hospital Narciso López
Lanús, Buenos Aires, Argentina
Hospital Héroes de Malvinas
Merlo, Buenos Aires, Argentina
Hospital Municipal Ostaciana B. de Lavignolle
Morón, Buenos Aires, Argentina
Hospital Materno Infantil de San Isidro
San Isidro, Buenos Aires, Argentina
Hospital Bocalandro
Tres de Febrero, Buenos Aires, Argentina
Hospital Maternidad Santa Rosa
Vicente López, Buenos Aires, Argentina
Hospital San Roque
Manuel B. Gonnet, La Plata, Argentina
Centro de Salud Badano Repetto
Montevideo, Montevideo Department, Uruguay
Centro de Salud Cerro
Montevideo, Montevideo Department, Uruguay
Centro de Salud Misurraco
Montevideo, Montevideo Department, Uruguay
Centro de Salud Saint Bois
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 1
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 2
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 3
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 4
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 5
Montevideo, Montevideo Department, Uruguay
Centro Materno Infantil 6
Montevideo, Montevideo Department, Uruguay
Hospital Canzani
Montevideo, Montevideo Department, Uruguay
Hospital Pereira Rossell
Montevideo, Montevideo Department, Uruguay
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Althabe F, Aleman A, Mazzoni A, Berrueta M, Morello P, Colomar M, Ciganda A, Becu A, Gibbons L, Llambi L, Bittar Gonzalez MG, Tong VT, Farr SL, Smith RA, Dietz PM, Johnson C, Buekens P, Belizan JM. Tobacco cessation intervention for pregnant women in Argentina and Uruguay: study protocol. Reprod Health. 2013 Aug 26;10(1):44. doi: 10.1186/1742-4755-10-44.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.